VivaScope® 1500 and 3000 systems for detecting and monitoring skin lesions: a systematic review and economic evaluation
Edwards SJ, Mavranezouli I, Osei-Assibey G, Marceniuk G, Wakefield V, Karner C
Record ID 32015000759
Authors' objectives: To evaluate the clinical effectiveness and cost-effectiveness of VivaScope® 1500 (Caliber Imaging and Diagnostics, Rochester, NY, USA; Lucid Inc., Rochester, NY, USA; or Lucid Inc., MAVIG GmbH, Munich, Germany) and VivaScope® 3000 (Caliber Imaging and Diagnostics, Rochester, NY, USA) in the diagnosis of equivocal skin lesions, and VivaScope 3000 in lesion margin delineation prior to surgical excision of lesions. Skin cancer is one of the most common cancers in the UK. The main risk factor is exposure to ultraviolet radiation from sunlight or the use of sunbeds. Patients with suspicious skin lesions are first examined with a dermoscope. After examination, those with non-cancerous lesions are discharged, but lesions that are still considered clinically suspicious are surgically removed. VivaScope® is a non-invasive technology designed to be used in conjunction with dermoscopy to provide a more accurate diagnosis, leading to fewer biopsies of benign lesions or to provide more accurate presurgical margins reducing the risk of cancer recurrence.
Authors' recomendations: The use of VivaScope appears to be a cost-effective strategy in the diagnostic assessment of equivocal melanomas and BCCs, and in margin delineation of LM prior to surgical treatment.
Project Status: Completed
URL for project: http://www.nets.nihr.ac.uk/projects/hta/146902
Year Published: 2016
URL for published report: http://www.journalslibrary.nihr.ac.uk/hta/hta20580/#/abstract
URL for additional information: http://www.nice.org.uk/guidance/indevelopment/gid-dt23
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England, United Kingdom
- Skin Neoplasms
- Sensitivity and Specificity
- Neoplasm Staging
- Image Processing, Computer-Assisted
Organisation Name: NIHR Health Technology Assessment programme
Contact Address: NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name: email@example.com
Contact Email: firstname.lastname@example.org
Copyright: Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.